2019 | | Korean Guideline of Glucocorticoid-induced Osteoporosis; Time to Prevent Fracture! | 서창희 |
2019 | | Clinical Impact of the Fracture Risk Assessment Tool on the Treatment Decision for Osteoporosis in Patients with Knee Osteoarthritis: A Multicenter Comparative Study of the Fracture Risk Assessment Tool and World Health Organization Criteria | 김현아, 서창희, 정주양 |
2019 | | Associated clinical factors for serious infections in patients with systemic lupus erythematosus | 김현아, 서창희, 윤덕용, 정주양, 최영 |
2019 | | Polymorphisms of MFGE8 are associated with susceptibility and clinical manifestations through gene expression modulation in Koreans with systemic lupus erythematosus | 김현아, 서창희, 정주양 |
2019 | | Efficacy and safety of switching from rituximab to biosimilar CT-P10 in rheumatoid arthritis: 72-week data from a randomized Phase 3 trial | 서창희 |
2019 | | Differences in Expression of Human Leukocyte Antigen Class II Subtypes and T Cell Subsets in Behcet's Disease with Arthritis | 김현아, 서창희, 손성향, 정주양 |
2019 | | The levels of CXCL12 and its receptor, CXCR4, as a biomarker of disease activity and cutaneous manifestation in adult-onset Still's disease | 권지은, 김현아, 서창희, 임현이, 정주양, 한재호 |
2019 | | Efficacy and safety of mycophenolate mofetil and tacrolimus combination therapy in patients with lupus nephritis: a nationwide multicentre study | 서창희 |
2019 | | Neutrophil Extracellular Traps May Contribute to the Pathogenesis in Adult-onset Still Disease | 권지은, 김현아, 서창희, 정주양, 최용준, 한재호 |
2019 | | Plasma Free Protein S Is Correlated with Disease Activity, but not with Subclinical Atherosclerosis among Patients with Systemic Lupus Erythematosus: A Cross-Sectional Study | 김현아, 서창희, 정주양 |
2019 | | NEUTROPHIL-TO-LYMPHOCYTE RATIO AND PLATELET-TO-LYMPHOCYTE RATIO ARE ASSOCIATED WITH DISEASE ACTIVITY IN POLYMYALGIA RHEUMATICA | 김지원, 김현아, 서창희, 정주양 |
2019 | | PREVALENCE OF OSTEOPOROSIS IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS: A MULTICENTER COMPARATIVE STUDY OF THE FRAX AND WHO CRITERIA | 김지원, 김현아, 서창희, 정주양 |
2019 | | CHARACTERIZATION OF SALIVARY PROTEINS IDENTIFIED AS POTENTIAL BIOMARKERS FOR SYSTEMIC LUPUS ERYTHEMATOSUS THROUGH PROTEOMIC ANALYSIS | 김지원, 김현아, 서창희, 정주양 |
2019 | | A RETROSPECTIVE ANALYSIS OF LONG TERM SAFETY UP TO FIVE YEARS OF INFLIXIMAB BIOSIMILAR CT-P13 IN PATIENTS WITH RHEUMATOID ARTHRITIS AND ANKYLOSING SPONDYLITIS | 서창희 |
2019 | | The role of damage-associated molecular pattern for pathogenesis and biomarkers in adult-onset Still's disease | 김현아, 서창희, 정주양 |
2019 | | Rituximab biosimilar CT-P10 for the treatment of rheumatoid arthritis | 김지원, 김현아, 서창희, 정주양 |
2019 | | Mindfulness-based cognitive therapy in Korean patients with systemic lupus erythematosus: A pilot study | 김현아, 서창희, 정주양, 조선미 |
2019 | | Neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio are associated with disease activity in polymyalgia rheumatica | 김현아, 서창희, 정주양 |
2019 | | Long-term efficacy, safety and immunogenicity in patients with rheumatoid arthritis continuing on an etanercept biosimilar (LBEC0101) or switching from reference etanercept to LBEC0101: an open-label extension of a phase III multicentre, randomised, double-blind, parallel-group study | 서창희 |
2019 | | Body mass index and glucocorticoid dose contribute to subclinical atherosclerosis in Korean patients with systemic lupus erythematosus: A prospective 4 year follow-up study | 김현아, 서창희, 정주양 |